newsfilter
← Latest News
GlobeNewswire·

ARS Pharma to Report Third Quarter 2026 Financial Results

SAN DIEGO, Oct. 28, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (NASDAQ:SPRY), a commercial biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients